Neoadjuvant Trastuzumab and Pertuzumab in Combination with Standard Chemotherapy for HER2-Positive Early Breast Cancer: Real-World Practice in Cuba.
Medina EAG, Caballero BB, Miguel KL, Gutiérrez ZA, Fernández BM, Tul LEA, Rodríguez LEM, Guerrero OV, Varela IGS, Bernardo MCC, Montero YC, Ortiz MR, Carrasco JM, Torres KP, Prado YID, Rubio MC, Braojo IMP.
Medina EAG, et al. Among authors: miguel kl.
Cancer Treat Res Commun. 2023;34:100670. doi: 10.1016/j.ctarc.2022.100670. Epub 2022 Dec 13.
Cancer Treat Res Commun. 2023.
PMID: 36549232
Free article.